{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:50:11Z","timestamp":1787593811528,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ejphar.2006.08.025","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T11:42:09Z","timestamp":1156851729000},"page":"1-8","source":"Crossref","is-referenced-by-count":35,"title":["Selection of new chemical entities with decreased potential for adverse drug reactions"],"prefix":"10.1016","volume":"549","author":[{"given":"Kevin B.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dalton-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.08.025_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-199706000-00002","article-title":"Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis","volume":"7","author":"Belloc","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejphar.2006.08.025_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002018-200124020-00004","article-title":"Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting","volume":"24","author":"Biswas","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2006.08.025_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/019262339602400206","article-title":"Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha","volume":"24","author":"Blazka","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","article-title":"Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis","volume":"9","author":"Bourdi","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1007443610025","article-title":"The use of cultured hepatocytes to investigate the mechanisms of drug hepatotoxicity","volume":"13","author":"Castell","year":"1997","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000235138","article-title":"Immunogenicity of amodiaquine in the rat","volume":"91","author":"Clarke","year":"1990","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/0024-3205(74)90092-7","article-title":"Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen","volume":"14","author":"Davis","year":"1974","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2006.08.025_bib8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/tx970090u","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide","volume":"10","author":"Dietze","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib9","first-page":"331","article-title":"Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient's serum","volume":"21","author":"Douer","year":"1985","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2006.08.025_bib10","first-page":"573","article-title":"Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis","volume":"50","author":"Eliasson","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199608)179:4<432::AID-PATH609>3.0.CO;2-S","article-title":"Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity","volume":"179","author":"Goldin","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.20183","article-title":"Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice","volume":"39","author":"Goldring","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2006.08.025_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1124\/dmd.31.11.1327","article-title":"Studies on the chemical reactivity of diclofenac acyl glucuronide with glutathione: identification of diclofenac-S-acyl-glutathione in rat bile","volume":"31","author":"Grillo","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2006.08.025_bib14","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0006-2952(92)90198-R","article-title":"The mechanism of bioactivation and antigen formation of amodiaquine in the rat","volume":"43","author":"Harrison","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002040100251","article-title":"Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes","volume":"75","author":"Haskins","year":"2001","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(86)92371-8","article-title":"Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria","volume":"1","author":"Hatton","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2006.08.025_bib17","doi-asserted-by":"crossref","first-page":"18415","DOI":"10.1016\/S0021-9258(18)55074-2","article-title":"Detection of cysteine conjugate metabolite adduct formation with specific mitochondrial proteins using antibodies raised against halothane metabolite adducts","volume":"266","author":"Hayden","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.08.025_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0024-3205(81)90278-2","article-title":"Acetaminophen-induced hepatotoxicity","volume":"29","author":"Hinson","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2006.08.025_bib59","unstructured":"Jayyosi, Z., Muc, M., Gallagher, M., Toutain, H., Stevens, J., Kelley, M. 1999. Covalent Binding of Troglitazone and other members of the thiazolidinedione family to human liver microsomes, implications for cases of idiosyncratic hepatotoxicity. Proceedings of 9th North American ISSX Meeting Abstract 398."},{"key":"10.1016\/j.ejphar.2006.08.025_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00498259509061845","article-title":"Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine","volume":"25","author":"Jewell","year":"1995","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2006.08.025_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2006.08.025_bib21","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/tx0255976","article-title":"Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice","volume":"15","author":"Ju","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/tx000180q","article-title":"Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission","volume":"14","author":"Kassahun","year":"2001","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.ejphar.2006.08.025_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0168-8278(97)82327-6","article-title":"Immunoallergic drug-induced hepatitis: lessons from halothane","volume":"26","author":"Kenna","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2125.1995.tb04560.x","article-title":"Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis","volume":"40","author":"Kitteringham","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1572-0241.2000.01707.x","article-title":"Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration","volume":"95","author":"Kohlroser","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/taap.1993.1097","article-title":"Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes","volume":"120","author":"Kretz-Rommel","year":"1993","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-104-6-801","article-title":"Amodiaquine-induced hepatitis. A report of seven cases","volume":"104","author":"Larrey","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2006.08.025_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2006.08.025_bib29","first-page":"326","article-title":"Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9","volume":"50","author":"Lecoeur","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib30","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1053\/j.gastro.2004.08.053","article-title":"Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity","volume":"127","author":"Liu","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2006.08.025_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0168-8278(92)90130-H","article-title":"Autoantibodies in experimental autoimmune hepatitis","volume":"14","author":"Lohse","year":"1992","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2006.08.025_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-2952(88)90733-2","article-title":"Drug-protein conjugates-XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man","volume":"37","author":"Maggs","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0006-291X(91)90161-Y","article-title":"A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-alpha but has no activity","volume":"178","author":"Martin","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.08.025_bib34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840180417","article-title":"Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase","volume":"18","author":"Martin","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2006.08.025_bib36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1124\/dmd.30.10.1143","article-title":"Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine","volume":"30","author":"Masubuchi","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2006.08.025_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/251508a0","article-title":"Hepatic necrosis caused by furosemide","volume":"251","author":"Mitchell","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.08.025_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","article-title":"Amodiaquine induced agranulocytosis and liver damage","volume":"292","author":"Neftel","year":"1986","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.ejphar.2006.08.025_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2008-1040482","article-title":"Molecular mechanisms of the hepatotoxicity caused by acetaminophen","volume":"10","author":"Nelson","year":"1990","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2006.08.025_bib40","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/jm030796n","article-title":"Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials","volume":"46","author":"O'Neill","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.08.025_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2005.10.185","article-title":"Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity","volume":"339","author":"Okawa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.08.025_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/tx980058f","article-title":"Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective","volume":"11","author":"Park","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib43","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/bmj.316.7140.1295","article-title":"Adverse drug reactions","volume":"316","author":"Pirmohamed","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2006.08.025_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0009-2797(02)00056-X","article-title":"Identification of glutathione conjugates of troglitazone in human hepatocytes","volume":"142","author":"Prabhu","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2006.08.025_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0003-9861(89)90278-6","article-title":"Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2","volume":"271","author":"Raucy","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2006.08.025_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0163-7258(89)90050-8","article-title":"Mechanisms of carbon tetrachloride toxicity","volume":"43","author":"Recknagel","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.08.025_bib47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bmj.292.6522.717","article-title":"Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents","volume":"292","author":"Rhodes","year":"1986","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.ejphar.2006.08.025_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/tx9802365","article-title":"Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac","volume":"12","author":"Shen","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/tx034033e","article-title":"Mechanisms of troglitazone hepatotoxicity","volume":"16","author":"Smith","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-9556(24)14912-4","article-title":"Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites","volume":"27","author":"Tang","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2006.08.025_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/tx0001981","article-title":"Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo","volume":"14","author":"Tettey","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib52","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0006-2952(93)90295-8","article-title":"Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4","volume":"45","author":"Thummel","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1089-3261(03)00020-5","article-title":"Hepatotoxicity of the thiazolidinediones","volume":"7","author":"Tolman","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejphar.2006.08.025_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM198007103030202","article-title":"Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis","volume":"303","author":"Vergani","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2006.08.025_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0009-9236(03)00014-6","article-title":"A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus","volume":"73","author":"Watanabe","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.08.025_bib56","first-page":"759","article-title":"Microsomal metabolism of furosemide evidence for the nature of the reactive intermediate involved in covalent binding","volume":"12","author":"Wirth","year":"1976","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/78475","article-title":"Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis","volume":"18","author":"Zhang","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2006.08.025_bib58","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/tx960069d","article-title":"The covalent binding of [14C]acetaminophen to mouse hepatic microsomal proteins: the specific binding to calreticulin and the two forms of the thiol:protein disulfide oxidoreductases","volume":"9","author":"Zhou","year":"1996","journal-title":"Chem. Res. Toxicol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600896X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600896X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T17:39:06Z","timestamp":1736530746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990600896X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":59,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S001429990600896X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.08.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}